![GP100111: Biotin-PEG2-Gly-MUC1(126-149)-Tn(131,144) label-new 4-c]pyridine-3-carboxamide-13C d3](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/agalnac-R_7e03cd8d-7c58-4ba5-bcfa-1adbfa685a65.svg?v=1772649622)
Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
4-c]pyridine-3-carboxamide-13C d3
GalNAc-PEG5K-SH
7-Dichloro-9-[(4-chlorophenyl)methylene]-a-[(dibutylamino)methyl]-9H-fluorene-4-methanol-d9
β-D-GalNAc(Ac)3-Butyl-COOH
98 / A triantennary N-acetylgalactosamine (Tri-GalNAcβ) ligand presenting three β-GalNAc residues on a tris-based branched scaffold
GP100111: Biotin-PEG2-Gly-MUC1(126-149)-Tn(131,144) label-new 4-c]pyridine-3-carboxamide-13C d3C130H205N35O48S 3058. 29 MUC1 (UniProt ID P15941) synthetic glycopeptide fragment (Pro126 Gly149; UniProt position 126 149, aa length 24) from the variable number tandem repeat (TR) domain. The fragment contains tumour associated carbohydrate antigen (TACA), Tn antigen (GalNAc) at Thr131 and Thr144. Biotin is conjugated at the N terminus of the sequence and is separated from peptide sequence by a discrete, monodisperse and amphiphilic diethylene
US$ 12.95
US$ 10.00
US$ 187.10
US$ 38.00
US$ 127.25
US$ 173.60
US$ 14.80
